Prokidney (PROK) Change in Accured Expenses (2021 - 2026)

Prokidney (PROK) has 6 years of Change in Accured Expenses data on file, last reported at -$6.0 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 0.93% year-over-year to -$6.0 million in Q1 2026; TTM through Mar 2026 was -$6.0 million, a 151.36% decrease from a year earlier, with the FY2025 full-year figure at -$5.9 million, down 151.06% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$6.0 million, down from $2.2 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for PROK reached as high as $13.0 million in Q2 2023 and fell as low as -$6.0 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged $697000.0 across 5 years, with a median of $104000.0 in 2024.
• On a YoY basis, Change in Accured Expenses climbed as much as 2736.08% in 2022 and fell as far as 2317145.45% in 2022.
• Year by year, Change in Accured Expenses stood at $533000.0 in 2022, then soared by 625.14% to $3.9 million in 2023, then jumped by 202.87% to $11.7 million in 2024, then tumbled by 81.58% to $2.2 million in 2025, then tumbled by 376.3% to -$6.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$6.0 million in Q1 2026, $2.2 million in Q4 2025, and $51000.0 in Q3 2025.